|
注册号: Registration number: |
ChiCTR1900024991 |
|
最近更新日期: Date of Last Refreshed on: |
2019-08-06 15:53:39 |
|
注册时间: Date of Registration: |
2019-08-06 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于医院和社区的烟草依赖管理模式优化研究 |
|
Public title: |
Research for Optimization of Tobacco Dependence Management Model Based on Hospital and Community |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于医院和社区的烟草依赖管理模式优化研究 |
|
Scientific title: |
Research for Optimization of Tobacco Dependence Management Model Based on Hospital and Community |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
金倩莹 |
研究负责人: |
李星明 |
|
Applicant: |
Jin Qianying |
Study leader: |
Li Xingming |
|
申请注册联系人电话: Applicant telephone: |
+86 18810958179 |
研究负责人电话:
Study leader's |
+86 13426073563 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
13967982543@163.com |
研究负责人电子邮件: Study leader's E-mail: |
libright2003@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市丰台区右安门外西头条10号首都医科大学 |
研究负责人通讯地址: |
北京市丰台区右安门外西头条10号首都医科大学 |
|
Applicant address: |
10 Xitoutiao, You'anmen, Fengtai District, Beijing, China |
Study leader's address: |
10 Xitoutiao, You'anmen, Fengtai District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
100069 |
研究负责人邮政编码: Study leader's postcode: |
100069 |
|
申请人所在单位: |
首都医科大学 |
||
|
Applicant's institution: |
Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学 |
||
|
Affiliation of the Leader: |
Capital Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
Z2019SY007 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Capital Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
1990-01-01 00:00:00 | ||
|
伦理委员会联系人: |
安魁 |
||
|
Contact Name of the ethic committee: |
An Kui |
||
|
伦理委员会联系地址: |
北京市丰台区右安门外西头条10号首都医科大学 |
||
|
Contact Address of the ethic committee: |
Capital Medical University, 10 Xitoutiao, You'anmen, Fengtai District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
首都医科大学 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Capital Medical University |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市丰台区右安门外西头条10号首都医科大学 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
10 Xitoutiao, You'anmen, Fengtai District, Beijing, China |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
国家科学技术部 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Ministry of Science and Technology of the People's Republic of China |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
烟草依赖 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Tobacco dependence |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
F17.2 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
F17.2 |
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
针对烟草依赖的群体干预措施,在现有医院戒烟干预模式的基础上,以世界卫生组织综合戒烟体系方案为指导,提出医院和社区联合开展的多部门合作戒烟管理模式并通过社区干预试验验证其效果。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
Based on the intervention measures of tobacco dependence, based on the existing hospital smoking cessation intervention model, and guided by the World Health Organization comprehensive smoking cessation system program, the multi-sector cooperation smoking cessation management mode jointly implemented by hospitals and communities was proposed and verified by community intervention trials. effect. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
30天内接受过其他戒烟治疗;患有严重的心、肺、脑、血液系统疾病,包括但不限于急性心肌梗死后2周内、严重心律失常、不稳定型心绞痛、药物控制不佳的高血压患者;患有精神疾病及吸毒者;怀孕或哺乳期妇女;经研究者判断处于其他无法达到研究要求的疾病或精神状态。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
Other smoking cessation treatments within 30 days; severe heart, lung, brain, and blood system diseases including, but not limited to, 2 weeks after acute myocardial infarction, severe arrhythmia, unstable angina, poorly controlled hypertension Patient; a person with mental illness and drug abuse; a pregnant or lactating woman; the investigator is judged to be in a state of illness or mental state that is unable to meet the research requirements. |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2017-07-10 00:00:00至 To 2020-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2018-12-01 00:00:00 至 To 2019-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
N/A |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
依申请分享; ResMan |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Share by application; ResMan |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
通过病例登记表进行数据收集,并录入网上数据系统中 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection is carried out through the case registration form and entered into the online data system. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |